Filing Details
- Accession Number:
- 0001645470-19-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-22 15:38:15
- Reporting Period:
- 2019-03-19
- Accepted Time:
- 2019-03-22 15:38:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-19 | 2,000 | $0.02 | 21,870,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-19 | 100 | $0.02 | 21,870,723 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-19 | 1,900 | $0.02 | 21,872,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-19 | 2,000 | $0.02 | 21,874,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-19 | 10,000 | $0.02 | 21,884,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-19 | 50 | $0.02 | 21,884,673 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-19 | 950 | $0.02 | 21,885,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-20 | 2,000 | $0.02 | 21,887,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-20 | 2,000 | $0.02 | 21,889,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-20 | 2,000 | $0.02 | 21,891,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-20 | 2,000 | $0.02 | 21,893,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-21 | 2,000 | $0.02 | 21,895,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-21 | 2,000 | $0.02 | 21,897,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-21 | 5,000 | $0.02 | 21,902,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-21 | 2,000 | $0.02 | 21,904,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-21 | 2,000 | $0.02 | 21,906,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-21 | 5,000 | $0.02 | 21,911,623 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
